...
【24h】

Accidental Pediatric Exposure to Imidazoline Derivatives

机译:小儿偶氮咪唑啉衍生物的意外接触

获取原文
获取原文并翻译 | 示例
           

摘要

When consumers reach for over-the-counter (OTC) eye drop solutions and nasal sprays, they are usually unaware that the relief they seek from eye redness or nasal congestion is elicited by the imidazoline derivatives present in their topical OTC product of choice. These products that contain imidazo-lines are marketed under a variety of names, including popular product brands like Visine and Afrin. Topical products that contain imidazolines frequently are regarded as innocuous staples of household medicine cabinets and, in fact, generally are sold without child-resistant closures. Nevertheless, when ingested accidentally by children, the imidazoline agonists contained in these products can cause a number of adverse events and serious harm. Adverse effects from accidental ingestion of these topical products by small children range in severity and include nausea, vomiting, diarrhea, dizziness, somnolence, hypothermia, tremors, blurred vision, muscle flaccidity, difficulty breathing, hypertension followed by hypotension, bradycardia, seizures, central nervous system (CNS) depression, coma, and death (U.S. Food and Drug Administration [FDA] Reporting System; cases from this database can be obtained through Freedom of Information [FOI] request). Literature reports describing accidental pediatric exposure after ingestion of topical OTC products containing imidazolines were published as early as 1948.5 A recent FDA review of the adverse events reported to the Agency between January 1985 and November 2011 identified 57 cases of accidental imidazoline ingestion by children (see the case illustration in the Figure). In addition, the U.S. Consumer Product Safety Commission (CPSC) published a Notice of Proposed Rulemaking in which they describe 12 cases from published literature and 172 cases from the Children and Poisoning system of accidental pediatric ingestion of imidazolines reported between 1948 and 2010 (the Children and Poisoning System represents a subset of National Electronic Injury Surveillance System: Cooperative Adverse Event Surveillance System [NEISS-CADES] records regarding pediatric poisoning, chemical burn, or ingestion).
机译:当消费者购买非处方(OTC)滴眼液和鼻喷剂时,他们通常不知道他们眼部发红或鼻塞所寻求的缓解是由他们所选择的局部OTC产品中存在的咪唑啉衍生物引起的。这些含咪唑啉的产品以多种名称销售,包括诸如Visine和Afrin的流行产品品牌。经常包含咪唑啉的外用产品被认为是家用药品柜的无害主食,实际上,通常在销售时不带防止儿童进入的密封件。但是,当儿童意外摄入时,这些产品中所含的咪唑啉激动剂可能会导致许多不良事件和严重伤害。幼儿意外摄入这些外用产品的不良反应的严重程度不等,包括恶心,呕吐,腹泻,头晕,嗜睡,体温过低,震颤,视力模糊,肌肉松弛,呼吸困难,高血压,其次是低血压,心动过缓,癫痫发作,中枢神经系统(CNS)抑郁,昏迷和死亡(美国食品和药物管理局[FDA]报告系统;可通过信息自由[FOI]请求获得该数据库中的病例)。早在1948.5年就发表了描述摄入含咪唑啉的局部OTC产品后意外儿科暴露的文献报告。最近FDA对1985年1月至2011年11月间向原子能机构报告的不良事件进行的审查确定了57例儿童意外摄入咪唑啉的情况(参见图中的案例说明)。此外,美国消费品安全委员会(CPSC)发布了《拟议法规制定通知》,其中描述了1948年至2010年间报告的12例来自已发表文献的案例以及172例儿童和儿童中毒摄入咪唑啉的儿童中毒事件(儿童中毒系统代表国家电子伤害监视系统的一个子集:关于儿童中毒,化学烧伤或摄入的合作不良事件监视系统[NEISS-CADES]记录。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号